small business Grant Search

The following government grants in the FederalGrants.com database contain the term small business in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) 93.847 PAR-18-744
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) 93.847 PAR-18-743
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-023
Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) 93.213, 93.279 PAR-18-742
Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-021
Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-022
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) 93.847, 93.855 RFA-DK-18-005
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-024
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). 93.121, 93.361, 93.393, 93.866 PA-18-739
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). 93.121, 93.361, 93.393, 93.866 PA-18-738
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) 93.847 PA-18-741
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) 93.310 RFA-RM-18-011
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) 93.113, 93.121, 93.233, 93.242, 93.279, 93.307, 93.361, 93.398, 93.837, 93.838, 93.839, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867 PAR-18-740
Project on Advanced Systems and Concepts for Countering Weapons of Mass Destruction (PASCC) 12.800 USAFA-PASCC-BAA-2016-CALL-0003
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) 93.242 PAR-18-737
Rehabilitation Research and Training Center (RRTC) on Community Living and Participation for People with Intellectual and Developmental Disabilities 93.433 HHS-2018-ACL-NIDILRR-RTCP-0262
Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional) 93.172 PAR-18-736
Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) 93.172 PAR-18-735
Behavioral Interventions Scholars 93.647 HHS-2018-ACF-OPRE-PD-1367
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) 93.121, 93.233, 93.273, 93.837, 93.838, 93.839, 93.865, 93.940 PAR-18-733
OJJDP FY 18 Initiative To Develop a Research-Based Practice Guide To Prevent and Reduce Youth Violence in Communities 16.123 OJJDP-2018-13554
Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 - Clinical Trial Not Allowed) 93.121, 93.273, 93.853, 93.865 PAR-18-734
BJA FY 18 Innovative Responses to Behavior in the Community: Swift, Certain, and Fair Supervision 16.828 BJA-2018-13614
State Trade Expansion Program (STEP) 59.061 OIT-STEP-2018-01
OJJDP FY 18 Second Chance Act Ensuring Public Safety and Improving Outcomes for Youth in Confinement and While Under Community Supervision 16.812 OJJDP-2018-13546
OJJDP FY 18 Juvenile Reentry Research and Evaluation Program 16.812 OJJDP-2018-13708
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) 93.846 PA-18-719
OJJDP FY 18 Mentoring Research Partners Program 16.726 OJJDP-2018-13512
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional) 93.213, 93.321, 93.393, 93.847 PAR-18-727
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) 93.839, 93.847, 93.866 PAS-18-730
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) 93.846 PA-18-718
OJJDP FY 18 Improving Juvenile Reentry Programs Capacity for Data Collection, Analysis, and Reporting 16.812 OJJDP-2018-13707
OJJDP FY 18 Redesign Study of OJJDP's Juveniles in Corrections Data Collections 16.540 OJJDP-2018-13564
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional) 93.242, 93.393, 93.394, 93.395, 93.396, 93.399, 93.865, 93.989 PAR-18-732
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) 93.393 PAR-18-731
Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (U24 Clinical Trial Not Allowed) 93.859 RFA-GM-18-003
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) 93.855 PA-18-724
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.855, 93.866 PA-18-722
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) 93.113, 93.172, 93.173, 93.242, 93.273, 93.307, 93.313, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.865, 93.866 PA-18-729
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) 93.846, 93.853, 93.867 PAR-18-721
Search Results 7121-7160 of 21220
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com